BAJAJHCAREPharmaceuticals
Bajaj Healthcare Ltd — PE Ratio & Valuation Analysis
₹290.10
-4.21%
Current P/E26.45xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E24.3x8.8% above avg
✅
16.7% Discount to Industry
BAJAJHCARE P/E 26.45x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹13.12 | ₹415 | 31.6x |
| 2023 | ₹15.59 | ₹376 | 24.1x |
| 2022 | ₹25.87 | ₹445 | 17.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Bajaj Healthcare Ltd Valuation
Bajaj Healthcare Ltd (BAJAJHCARE) currently trades at 26.45x earnings. The Pharmaceuticals sector average PE is 31.77x. BAJAJHCARE is trading at a discount to peers — may indicate relative value. Historically, BAJAJHCARE has traded at an average PE of 24.3x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
10.69%
Dividend Yield
0.23%
More on Bajaj Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.